Prestige Consumer Healthcare: Better Valuation, But Too Much Uncertainty To Buy

Prestige ended its Fiscal Year 2026 with a big earnings miss. It appears the company will have a fairly slow start to FY'27 as well. Acquisitions should add significantly to the top line, but they will add more debt to an already leveraged balance sheet.